Jordan Daily – Jordan Food and Drug Administration (JFDA) has announced a cut in the prices of 391 commonly used medications during the first half of this year. The price cuts range from 2% to 47%, providing cost relief to citizens.
According to Nizar Muhaidat, the Director General of JFDA, the price reduction will be noticeable on pharmacy shelves as the imported medicines are gradually introduced. The affected medications include various types used for blood pressure, diabetes, heart conditions, antibiotics, respiratory diseases, nervous system disorders, bone and muscle ailments, and other commonly prescribed drugs.
Muhaidat emphasized that the drug price reduction program is a key priority for the Administration , with an ongoing work plan for periodic price reviews and reassessments. The JFDA aims to further reduce prices for other therapeutic categories in the future, aligning with the royal directives to ensure medication security and accessibility for citizens.
This move by the JFDA underscores its commitment to promoting affordable healthcare and meeting the medical needs of the Jordanian population. The price reductions are expected to provide substantial relief to patients and contribute to enhancing the accessibility of essential medications in the country, Muhaidat noted.
